Defining the Active Site of Yeast Seryl-tRNA Synthetase
MUTATIONS IN MOTIF 2 LOOP RESIDUES AFFECT tRNA-DEPENDENT AMINO ACID RECOGNITION*

(Received for publication, August 8, 1996, and in revised form, October 9, 1996)

Boris Lenhard Dagger §, Sanda Filipic Dagger §, Irena Landeka Dagger §, Ivan Skrtic §, Dieter Söll and Ivana Weygand-Durasevic Dagger §par

From the  Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520-8114, Dagger  Department of Chemistry, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia, and § Rudjer Boskovic Institute, 10000 Zagreb, Croatia

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The active site of class II aminoacyl-tRNA synthetases contains the motif 2 loop, which is involved in binding of ATP, amino acid, and the acceptor end of tRNA. In order to characterize the active site of Saccharomyces cerevisiae seryl-tRNA synthetase (SerRS), we performed in vitro mutagenesis of the portion of the SES1 gene encoding the motif 2 loop. Substitutions of amino acids conserved in the motif 2 loop of seryl-tRNA synthetases from other sources led to loss of complementation of a yeast SES1 null allele strain by the mutant yeast SES1 genes. Steady-state kinetic analyses of the purified mutant SerRS proteins revealed elevated Km values for serine and ATP, accompanied by decreases in kcat (as expected for replacement of residues involved in aminoacyl-adenylate formation). The differences in the affinities for serine and ATP, in the absence and presence of tRNA are consistent with the proposed conformational changes induced by positioning the 3'-end of tRNA into the active site, as observed recently in structural studies of Thermus thermophilus SerRS (Cusack, S., Yaremchuk, A., and Tukalo, M. (1996) EMBO J. 15, 2834-2842). The crystal structure of this moderately homologous prokaryotic counterpart of the yeast enzyme allowed us to produce a model of the yeast SerRS structure and to place the mutations in a structural context. In conjunction with structural data for T. thermophilus SerRS, the kinetic data presented here suggest that yeast seryl-tRNA synthetase displays tRNA-dependent amino acid recognition.


INTRODUCTION

The formation of aminoacyl-tRNA, catalyzed by aminoacyl-tRNA synthetases, is a crucial step in maintaining the fidelity of protein biosynthesis. This family of enzymes can be partitioned into two classes of 10 enzymes each, based on conserved sequences (1) and structural motifs (2). All members of class I contain a common loop with the signature sequence KMSKS (3) and a region of homology with the HIGH peptide (4) as part of a Rossmann dinucleotide binding fold of parallel beta -sheets (5). Class II synthetases have a different topology of dinucleotide binding based on antiparallel beta -sheets (2, 6, 7). The three common signature motifs of class II synthetases are found in this domain. Motif 1 forms part of the conserved inter-subunit interface of homodimeric (6, 8) and heteromeric (9) synthetases. Motifs 2 and 3 contain many of the active-site residues important for ATP, amino acid, and tRNA acceptor stem recognition (10, 11, 12, 13, 14, 15). The elucidation of the crucial role of sequence motifs in substrate binding have resulted from the solution of several crystal structures of enzymes and enzyme-substrate complexes from both class I and class II (16) and numerous biochemical studies involving mutant synthetases (17, 18, 19, 20, 21, 22).

The evolution of tRNA recognition systems has recently gained much attention (23, 24, 25, 26, 27). The primary structure of several prokaryotic and eukaryotic seryl-tRNA synthetases (Ref. 23; see also the legends to Fig. 1 and 3), including the enzyme that probably functions in yeast mitochondria (28), have been determined. While two prokaryotic enzymes, from Escherichia coli and Thermus thermophilus, have been crystallized in different complexes with substrates and subjected to biochemical analysis in order to identify the domains important for tRNA and amino acid binding (23), information on structure/function relationships in eukaryotic seryl-tRNA synthetases is still scarce by comparison. In contrast to their prokaryotic counterparts, these enzymes contain C-terminal extensions abundant in basic amino acids, which may be important for both stability and optimal substrate recognition in eukaryotic SerRS,1 as recently shown for yeast SerRS (29). To gain further insight into the mechanisms of substrate recognition employed by yeast SerRS and to identify catalytically important residues in the active site, we have replaced a number of amino acids in the motif 2 loop and analyzed the resulting mutants in vivo and in vitro. The altered kinetic parameters of the mutant SerRS proteins correlate with predictions based upon structural studies of the prokaryotic system.


Fig. 1. Unrooted tree of seryl-tRNA synthetases based on whole sequences alignment. BS, Bacillus subtilis (accession no. P37464[GenBank]); CB, Coxiella burnetii (P39919[GenBank]); EC, E. coli (P09156[GenBank]); HI, H. influenzae (P43833[GenBank]); HS, Homo sapiens (P49591[GenBank]); MG, Mycoplasma genitalium (P47251[GenBank]); TT, T. thermophilus (P34945[GenBank]); SC, S. cerevisiae (P07284[GenBank]); SCM, S. cerevisiae (putative mitochondrial, P38705[GenBank]); HM, H. marismortui (EMBL X91007[GenBank]); CE, Caenorhabditis elegans (EMBL Z68882[GenBank]); AT, Arabidopsis thaliana (EMBL Z70313[GenBank]). The accession numbers are from SwissProt, except where indicated. The tree was constructed using CLUSTALW (34) and PROTDIST, NEIGHBOR, and DRAWTREE of the PHYLIP package (35).
[View Larger Version of this Image (17K GIF file)]



MATERIALS AND METHODS

General Materials

[3H]Serine (30.0 Ci/mmol) was from Amersham Corp. [14C]Serine (166.1 mCi/mmol) and tetrasodium [32P]pyrophosphate (3.09 Ci/mmol) were purchased from DuPont NEN.

Plasmids and Strains

In vitro mutagenesis of the SES1 gene was carried out (see below) in pBluescript SK(-), where the BamHI cassette containing SES1 (30) was inserted, giving pSKSES1. The resulting mutant SES1 genes, named SES1mut, were recloned as 1.4-kilobase pair BamHI fragments into pVTL-100 behind the ADH (alcohol dehydrogenase) promoter and pCJ11 behind the GAL promoter for complementation of the null-allele strains, or in pET3 behind the T7 RNA polymerase promoter for overproduction of mutated proteins in E. coli (29, 30). Construction of the Saccharomyces cerevisiae SES1 disruption strain BR2727Delta SES1 (MATa ade2-1 arg4-9 his4 leu2-3, 112 lys2 trp1 ura3-1 SES1::LYS2) has been described (29). The deletion could be rescued by supplying a functional SES1 gene on a centromeric plasmid pUN70 (29). Selected haploids with a disrupted SES1 gene (Lys+ phenotype), where SerRS function was provided in trans (from pUN70SES1 plasmid), were used for complementation experiments via plasmid shuffling involving pVTL-100SES1mut. Since the parental strain BR2727 was not fully galactose-inducible, as shown by its inability to ferment galactose after streaking the colonies on bromthymol blue indicator plates (1% yeast extract, 2% peptone, 2% agar, 2% galactose, and 80 mg/liter bromthymol blue; Ref. 31), pUN70SES1 transformants of BR2727Delta SES1 were crossed with S. cerevisiae S2088 (MATalpha ura3-52 trp 1 lys2-801 leu2Delta 1 his3-Delta 200 pep4::HIS3 prb-Delta 1.6R can 1 GAL). Diploids were sporulated, tetrads dissected, and haploid segregants of the pUN70SES1 transformant with a disrupted SES1 gene (Lys+ phenotype) and the ability to ferment galactose (produce a yellow halo on indicator plates) were selected. The strain was named SD816 and used for complementation experiments via plasmid exchange with pCJ11SES1mut.

In Vitro Mutagenesis

Saturation mutagenesis was performed with a 5:1 molar ratio of synthetic phosphorylated oligonucleotides to U-containing single-stranded pSKSES1 DNA. A mutagenic oligonucleotide, a 50-mer complementary to the codons corresponding to amino acids 278-294, was synthesized doped to 4% with an equal mixture of A/C/G/T at all positions. A new NcoI restriction site was introduced internally by silent mutations to allow screening by restriction analysis. Annealing, extension, and ligation of the mutagenic mixture was as described (32). After transformation of E. coli DH5alpha , plasmid DNA was isolated from a large pool of individual transformants. The pertinent regions of all NcoI-containing pSKSES1 plasmids were subjected to sequencing in order to determine the mutational changes. Multiple mutations in the SES1 gene were separated by exchanging either 880-base pair PstI/NcoI or 560-base pair NcoI/EagI fragments with the corresponding fragments of pSKSES1wt.

Purification of Mutant SerRS from an E. coli Overproducing Strain

The overproduction of mutated SerRS enzymes was achieved by transformation of E. coli strain BL21(DE3) with pET3SES1mut constructs, followed by induction of the cultures with 2 mM isopropyl-1-thio-beta -D-galactopyranoside. The enzymes were purified by a two-step chromatographic procedure on FPLC MonoQ and MonoS columns (Pharmacia Biotech Inc.) as described previously (30).

Determination of Kinetic Parameters

The extent of adenylate formation catalyzed by the purified enzymes was assessed by pyrophosphate exchange at 30 °C (33). The reaction was performed in a buffer consisting of 100 mM Hepes/KOH, pH 7.2, 10 mM MgCl2, 0.5 mM [32P]PPi (1-2 cpm/pmol), 10 mM KF, containing various amounts of the substrate studied (serine or ATP), while the other substrate was kept saturating (serine at 5 mM, Mg-ATP at 2 mM (molar ratio 1:1)). Typical concentrations of the substrate studied were from 0.1 to 10 times Km. The concentration of wild-type enzyme was 45 nM, while the mutants were used in a concentration range from 45 to 450 nM.

Aminoacylation was done at 30 °C as described previously (29) in reaction mixtures containing 50 mM Tris-HCl, pH 7.5, 15 mM MgCl2, 4 mM dithiothreitol. For all kinetic assays, the concentrations of the substrate studied ([3H]serine, Mg-ATP, or tRNASer) were varied from 0.1 to 10 times Km. Saturating concentrations of other substrates were: 5 mM ATP, 12 mg/ml unfractionated brewer's yeast tRNA (Boehringer Mannheim), which corresponds to approximately 20 mM tRNASer, and 1 mM 3H- or 14C-labeled serine. To correct for the low counting efficiency of the free [3H]Ser in comparison to that of [3H]Ser-tRNA, total charging assays with either 3H- or 14C-labeled Ser were performed in parallel so that the conversion factor could be calculated. Enzyme concentrations were 94 nM for wild-type SerRS and 94-470 nM for mutants. Kinetic parameters were determined from Hanes-Woolf plots. All values represent the average of three independent determinations, which varied by less than 10%.

Sequence Analysis and Protein Modeling

Multiple alignment of protein sequences was performed using CLUSTALW (34). The PHYLIP package (35) was used to calculate protein distance matrices and to construct phylogenetic trees. Percent similarities between proteins were calculated by the method of Myers and Miller (36). Theoretical models of the yeast SerRS three-dimensional structure were produced and optimized using the PROMOD program suite (37).2 Images were produced using RasMol Molecular Renderer version 2.6.


RESULTS AND DISCUSSION

Similarity among Prokaryotic and Eukaryotic Synthetases

There is significant similarity among the primary structures of all known SerRS proteins. Pairwise similarities range from 26% between S. cerevisiae cytoplasmic and a recently identified S. cerevisiae putative second SerRS (28) to 78% between E. coli and Haemophilus influenzae SerRS. The second yeast SerRS is most likely a mitochondrial enzyme. This is based on its position in the phylogenetic tree, the presence of a putative N-terminal mitochondrial targeting sequence (as diagnosed by multiple sequence alignment, and with high confidence by the method of Nakai and Kanehisa; Ref. 38)3 and the lack of a C-terminal extension (29). The phylogenetic tree showing evolutionary relationships among seryl-tRNA synthetases from different organisms is presented in Fig. 1. The cytoplasmic enzymes of eukaryotes form a separate group, and the divergence pattern of eubacterial enzymes is in accord with the contemporary phylogenetic trees (39). Surprisingly, an archaeal SerRS (Haloarcula marismortui) clusters with the enzymes of B. subtilis and the three Gram-negative bacteria regardless of the method used to construct the tree. This suggests that, at some point in evolution, a eubacterial gene for SerRS replaced the ancestral H. marismortui gene by horizontal transfer.

In spite of primary sequence similarity, immunological cross-reactivity has been observed neither between eukaryotic and prokaryotic seryl-tRNA synthetases nor between the cytoplasmic and organellar proteins (40, 41). As revealed by the crystal structures of two prokaryotic seryl-tRNA synthetases from E. coli (2) and T. thermophilus (42), each subunit of the homodimeric enzymes is composed of two domains: an N-terminal "helical arm" comprising a 60-Å solvent-exposed, antiparallel coiled-coil, which binds the variable arm of cognate tRNASer (12, 43) and the catalytic domain based on a seven-stranded antiparallel beta -sheet. The mode of seryl-adenylate binding in the active site is also known from crystallographic and solution studies (10, 11, 13). However, none of the eukaryotic seryl-tRNA synthetases have yet been crystallized, nor is there any information on substrate binding domains and catalytic sites from biochemical experiments. In our search for the active site of yeast SerRS, we have performed saturation in vitro mutagenesis of the portion of the SES1 gene encoding the domain that in the model structure based upon the coordinates of SerRS from T. thermophilus (Fig. 2), corresponds to the active site loop in motif 2 (residues 278-294 in yeast SerRS) (Fig. 2). As shown by primary sequence alignment (Fig. 3), this is the most conserved region among all SerRS proteins.


Fig. 2. Top, superposition of the x-ray structure of the T. thermophilus SerRS monomer (gray) and a model structure of yeast cytoplasmic SerRS, amino acids 1-442 (red). The motif 2 loop of T. thermophilus SerRS (residues 256-273) is shown in blue, and that of yeast SerRS (residues 279-296) in green.The C-terminal extension of the yeast enzyme (residues 443-462), absent in its prokaryotic counterparts (29), was not modeled. The structure of T. thermophilus SerRS was drawn from Protein Data Bank entry 1ses.pdb. Bottom, superposition of models of motif 2 loops in wild-type SerRS (green) and SerRS2 (R279C/E281Q/G283A/D288V/W290L) (purple). This particular mutated protein carries amino acid substitutions that severely affect the activity of the enzyme. The models of yeast enzymes were produced and optimized by the ProMod program suite via the SwissModel automated knowledge-based protein modeling server. The optimized model is based on alignment of the yeast and T. thermophilus sequence extracted from a multiple alignment of all 12 known SerRS sequences produced by CLUSTALW (34). The seryl-adenylate analog, colored according to the atom type, is positioned with respect to the motif 2 loop as in the T. thermophilus crystal structure (10).
[View Larger Version of this Image (46K GIF file)]



Fig. 3. A, sequence alignment of SerRS motif 2 regions. Abbreviations used are the same as in Fig. 1. Fully conserved residues are shown in bold. B, the type and the position of amino acid changes in mutant yeast SerRSs. Saturation mutagenesis was performed using oligonucleotides complementary to the codons corresponding to amino acids 278-294 (shaded) in yeast SerRS.
[View Larger Version of this Image (49K GIF file)]


In Vivo Analysis of SerRS Mutants

From the many SerRS mutants isolated, which carry one to five amino acid substitutions in region 278-294 of the motif 2 loop, we wanted to select those with the most severely affected substrate binding or catalytic properties. This was first assessed in vivo by the ability of the mutants to complement S. cerevisiae SES1 null-allele strains via plasmid shuffling (Table I). The haploid strain BR2727Delta SES1 (where viability of the cell is ensured by a wild-type SES1 gene on the URA3-containing plasmid pUN70SES1), was transformed with pVTL-100SES1mut constructs (which carry the LEU2-selectable marker and SES1mut behind the ADH promoter). Four of the motif 2 loop mutants were found to have lost the ability to complement the Delta SES1 null allele. They were named SES1mut2, SES1mut3, SES1mut4, and SES1mut5. The type and the position of mutational changes in the resulting SerRS proteins are presented in Fig. 3B. In order to check whether the function of wild-type SerRS can be restored by the overproduction of mutated SerRS proteins, the complementation of S. cerevisiae SD816 (which also carries an inactivated SES1::LYS2 allele but has a normal galactose uptake), was performed via plasmid shuffling with pCJ11SES1mut constructs. After induction of the GAL promoter by switching the cultures of SD816/pCJ11SESmut from glucose to galactose medium, significant amounts of mutant proteins accumulated in the cell, as detected by SDS-polyacrylamide gel analysis of protein extracts (not shown). pUN70SES1 was cured by growing induced double transformants in the presence of uracil, followed by plating the cells on selective galactose plates. Lys+Leu+ colonies were replica-plated to 5-fluoro-orotic acid-containing medium (31), which counterselects against colonies containing URA3 plasmids carrying the wild-type S. cerevisiae SES1 gene. Some very slow growing transformants of pCJ11SES1mut4 and pCJ11SES1mut5 appeared on 5-fluoro-orotic acid plates after several days of incubation at 30 °C, while all the cells containing pCJ11SES1mut2 or pCJ11SES1mut3 as the only source of seryl-tRNA synthetase activity were nonviable (Table I). It is thus apparent that several amino acid substitutions between residues 278 and 294 of yeast SerRS are responsible for enzyme inactivation and consequently for the phenotypic alteration.

Table I.

In vivo activity of SerRS mutants


Gene Complementationa
Accumulation in the cellb
pVTL-100 SES1mut pCJ11SES1mut

SES1 + + +
SES1mut2  -  - +
SES1mut3  -  - +
SES1mut4  - ± - +
SES1mut5  - ± - +

a  +, complementation of the SES1 null-allele strains BR2727Delta SES1 with pVTL-100SES1mut or SD816 with pCJ11SES1mut; -, no complementation; ± -, marginal complementation (minimal growth).
b  +, full-length protein detected by Western blot analysis at a level comparable to SerRSwt when expressed from the same vector. This was tested in crude cell extracts containing overexpressed mutant proteins before curing the cells for pUN70SES1.

Purification and in Vitro Characterization of SerRS Mutants

To determine the steps of the aminoacylation reaction at which the altered enzymes are defective, noncomplementing (SES1mut2 and SES1mut3) or weakly complementing mutants (SES1mut4 and SES1mut5) which normally accumulate in yeast cells (Table I) were overexpressed in E. coli, purified to apparent homogeneity as described under "Materials and Methods," and characterized in vitro. As discussed previously (29), there are some indications that S. cerevisiae SerRS purified from bacterial overproducing strains may differ in modification and/or conformation compared to the native protein. However, since the kinetic parameters for overexpressed yeast SerRS are very much alike regardless of the overproducing system used (29, 30), the comparison of the substrate binding and catalytic constants for the wild-type and mutant yeast SerRS was performed with proteins isolated from E. coli.

Since the aminoacylation assay did not reveal significant changes in the affinity for tRNA (Table II), but instead showed impaired ATP and serine binding capacities resulting in elevated Km values for both substrates accompanied by decreased turnover rates, the impact of the mutations on the steady-state kinetic parameters were independently determined in the amino acid activation reaction. Mutants SerRS2 (R279C/E281Q/G283A/D288V/W290L) and SerRS3 (R279P/A282R) have no detectable in vitro enzyme activity and could not be used for kinetic studies. This is in agreement with the inability of SES1mut2 and SES1mut3 to substitute for the wild-type SES1 function in vivo. In both mutants Arg279, which aligns with an invariant arginine in the class II synthetases, was replaced with other amino acids. This change probably causes the major inactivating effect in SerRS2 and SerRS3, since this position corresponds to Arg256 in T. thermophilus SerRS, which is in direct contact with the phosphate of the seryl-adenylate. Superposition of the models of the wild-type and SerRS2 motif 2 loops, with the seryl-adenylate analog positioned as in the crystal structure of T. thermophilus SerRS (10), is shown in Fig. 2. In order to determine the contribution of particular amino acid alterations, to enzyme function, the five mutations found in SerRS2 were separated. This was achieved by reconstruction of pSKSES1mut2, carrying the unique NcoI site introduced in SES1 as silent mutations at the position of the Gly260 and Ser261 codons. The PstI-NcoI and NcoI-EagI fragments of pSKSES1mut2 were individually replaced with corresponding fragments excised from pSKSES1wt. The new constructs, named SES1mut6 and SES1mut7, recloned as BamHI cassettes behind the T7 promoter of pET3, were used for the overproduction of SerRS6 (R279C/E281Q/G283A) and SerRS7 (D288V/W290L), respectively. As expected, the mutation of three absolutely conserved residues in motif 2 (see below), render the mutant SerRS6 totally inactive in both the amino acid activation and aminoacylation reactions. The kinetic analysis of SerRS7 showed slightly reduced specificity constants for both ATP and serine, relative to the wild-type enzyme. The affinity for tRNA of this mutant was slightly increased. This is of considerable interest, since the occurrence of tryptophan at position 290 is unique to yeast SerRS, and thus could be expected to be involved in tRNA binding. All other seryl-tRNA synthetases contain an arginine or lysine at this position. The exception is SerRS from A. thaliana, which contains a leucine. This indicates that the replacement of one bulky and hydrophobic amino acid (Trp) for another (Leu) is tolerated.

Table II.

Kinetic parameters for wild-type and mutant SerRS enzymes (aminoacylation and PPi exchange reaction at 30 °C)


Enzyme Aminoacylation
PPi exchange
kcat Km Relative kcat/Km kcat Km Relative kcat/Km

s-1 M s-1 M
Ser
  SerRS 0.97 6.3  × 10-5 1 3.8 4.5  × 10-4 1
  SerRS4 0.03 4.2  × 10-4 0.005 0.085 6.0  × 10-4 0.017
  SerRS5 0.03 7.0  × 10-4 0.003 0.055 8.9  × 10-4 0.007
  SerRS7 0.55 2.0  × 10-4 0.18 2.1 8.0  × 10-4 0.32
  SerRS8 0.085 2.1  × 10-4 0.026 0.091 4.5  × 10-4 0.024
  SerRS9 0.036 2.3  × 10-4 0.010 0.052 4.6  × 10-4 0.014
  SerRS10 0.45 1.7  × 10-4 0.17 2.0 4.7  × 10-4 0.52
ATP
  SerRS 0.99 2.5  × 10-5 1 3.5 4.0  × 10-6 1
  SerRS4 0.051 5.5  × 10-4 0.023 0.074 4.8  × 10-5 0.002
  SerRS5 0.031 3.0  × 10-4 0.026 0.041 4.0  × 10-5 0.001
  SerRS7 0.51 1.3  × 10-4 0.10 1.6 3.7  × 10-5 0.050
  SerRS8 0.095 3.5  × 10-4 0.007 0.079 3.4  × 10-5 0.003
  SerRS9 0.043 4.5  × 10-4 0.002 0.04 2.5  × 10-5 0.018
  SerRS10 0.42 6.0  × 10-5 0.18 1.97 1.0  × 10-5 0.23
tRNASer
  SerRS 1.1 1.9  × 10-7 1
  SerRS5 0.057 3.5  × 10-7 0.028
  SerRS7 0.65 1.0  × 10-7 1.12

Kinetic analysis of the aminoacylation and amino acid activation reactions revealed that substitution of the class II invariant glycine in SerRS4 (G291V) and SerRS5 (E281D/G291A) has the most dramatic effect on ATP and serine binding. The enzymes exhibit more than an order of magnitude elevated Km for ATP and 35-fold decrease in kcat. The parameters for serine were changed to a similar extent, while the Km for the tRNA (for mutant SerRS5) is almost identical to the wild-type value. Gly291 of yeast SerRS occupies a position that is strictly conserved in the primary structures of all prokaryotic and eukaryotic seryl-tRNA synthetases. Its analogue is not exposed in the active site of the T. thermophilus enzyme, thus it is probably involved in maintaining an overall motif 2 loop conformation (10). As recently discussed by Cusack et al. (13), the occurrence of several glycines in the loop, surrounded by other small residues, may provide the necessary flexibility and reduced steric hindrance to facilitate the conformational switch imposed by tRNA binding. In agreement with this structural data, alteration of the nonpolar Ala282 in yeast SerRS (mutant SerRS10) to serine, another small but polar amino acid, causes the least dramatic change in kinetic parameters.

To single out the effect of the E281D replacement, two mutations in SES1mut5 were separated by the same experimental procedure as described above for SES1mut2. Two new mutant enzymes were obtained by expression of the reconstructed SES1mut8 and SES1mut9 genes: SerRS8 (E281D) and SerRS9 (G291A), respectively. Glu281 in yeast SerRS is of special interest since it aligns with Glu258 in T. thermophilus SerRS, which is a part of the Arg256-X-Glu peptide. The side chain conformation of this residue is fixed upon binding of ATP or adenylate, which is believed to be the first step toward the stabilization of the motif 2 loop, which is also involved in tRNA acceptor stem interactions (10, 13). Glu258 is severely reoriented upon tRNA binding, making direct contact with the discriminator base. In yeast SerRS, Glu281 is also apparently involved in ATP binding, since its replacement with Asp, which only differs in side chain length results in a severe elevation of Km for ATP (from 18- to 8-fold) accompanied by an approximately 8-10-fold decreased turnover rate, in the aminoacylation and PPi exchange reactions, respectively (Table II). Furthermore, while PPi exchange does not reveal a change of the Km value of SerRS8 with respect to serine, aminoacylation shows a 3.6-fold elevation of Km compared to wild-type. The substitution Gly291 right-arrow Ala in SerRS9 has a similar impact on the steady-state kinetic parameters.

Mechanistic Implications of Mutating the Motif 2 Loop of Yeast SerRS

Crystallographic and biochemical data have shown that the specific recognition of cognate tRNASer by prokaryotic SerRS depends on the mutual interaction of two structural elements that are unique to the serine system: the alpha -helical coiled-coil (helical arm) in the enzyme, with the long variable arm of the tRNA (12, 13). The importance of the variable arm as the crucial identity element for tRNASer recognition has been demonstrated in both prokaryotic (44, 45, 46) and eukaryotic (47) systems. Since the N-terminal polypeptide of yeast SerRS, comprising 107 amino acids, can be modeled into a coiled-coil that resembles the corresponding structural element of T. thermophilus SerRS (Fig. 2), it seems likely that similar interactions govern tRNASer recognition in yeast. According to the recent experiments of Cusack et al. (13), the acceptor stem of tRNASer interacts with the motif 2 loop of the active site, causing a conformational switch in this protein domain. Although the correct positioning of the 3' end of tRNA in the active site of yeast SerRS may be disturbed by the alteration of amino acid residues in the putative loop, the kinetic parameters for tRNA do not change dramatically. Despite their critical role in aminoacylation, motif 2 loop residues generally contribute only weakly to the total tRNA-enzyme binding energy, as revealed by the small changes in Kd for tRNA of the inactive yeast aspartyl-tRNA synthetase enzymes mutated in this region (14). Possible effects of mutations in the active site on the rate of amino acid transfer, which is commonly rate-limiting for aminoacylation (see below), were reflected in our experiments by reduced catalytic efficiencies for both ATP and serine (Table II), as would be expected for substitution of residues involved in the catalysis of aminoacyl-adenylate formation.

The Km values for wild-type yeast SerRS, with respect to both ATP and serine, are considerably different when determined by the PPi exchange or aminoacylation reactions. The affinity for serine is more than an order of magnitude higher in the reaction performed in the presence of tRNA rather than in the activation step. Furthermore, the apparent affinity of SerRS for serine, as measured during seryl-adenylate formation, is not significantly changed by amino acid replacements. In contrast, an order of magnitude difference in Km values for wild-type and mutant SerRS, with respect to serine, was observed during aminoacylation. These results are consistent with the possibility that new binding sites for serine are created upon tRNA binding. When the kinetic data presented here are considered in conjunction with structural data for T. thermophilus SerRS, it is clear that SerRS displays tRNA-dependent amino acid recognition, as described previously for E. coli glutaminyl- and tryptophanyl-tRNA synthetases (48).

In agreement with the T. thermophilus SerRS structural studies, the apparent affinity for ATP to the yeast enzyme decreases 6.3-fold in the aminoacylation reaction compared to PPi exchange. This may support the idea that conformational changes in the active site are induced by substrate binding, as recently observed for eukaryotic aspartyl- (14) and prokaryotic seryl-tRNA synthetases (13). Mutational changes in the 278-294 region of yeast SerRS may interfere with the proposed structural flexibility essential to the function of the motif 2 loop. It is also likely that the impaired interaction of mutant SerRS enzymes with ATP and serine makes the amino acid activation reaction, instead of the transfer reaction, rate-limiting. This conclusion is based on the comparison of the kcat values for wild-type and mutant enzymes in PPi exchange and aminoacylation. In contrast to wild-type SerRS, which more rapidly turns over ATP and serine in the absence of tRNA, the catalytic rate constants characterizing the most affected mutant proteins (SerRS4 and SerRS5) are comparable in the activation and aminoacylation reactions. In summary, the results of in vivo and in vitro functional analyses of yeast SerRS mutants, combined with structural data for theT. thermophilus and E. coli enzymes which allowed the prediction of yeast SerRS structure, strongly suggest that seryl-tRNA synthetase from S. cerevisiae structurally and functionally resembles its prokaryotic counterparts in the active site.


FOOTNOTES

*   This work was supported by grants from National Institutes of Health (NIH), NIH/Fogarty International Collaboration Award, and United Nations Industrial Development Organization. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
par    To whom correspondence should be addressed: Dept. of Chemistry Faculty of Science, University of Zagreb, Strossmayerov trg 14, 10000 Zagreb, Croatia. Tel.: 385-1-456-1197; Fax: 385-1-425-497; E-mail: weygand{at}olimp.irb.hr.
1    The abbreviation used is: SerRS, seryl-tRNA synthetase.
2    The PROMOD program suite is implemented on the Internet via the SwissModel server (http://expasy.hcuge.ch/swissmod/SWISSMODEL.html).
3    This method for analyzing and predicting protein sorting signals coded in amino acid sequence is implemented on the Internet as a part of the PSORT WWW server (http://psort.nibb.ac.jp/).

Acknowledgments

We are indebted to Nenad Ban, Michael Ibba, and Sanja Sever for critical discussions.


REFERENCES

  1. Eriani, G., Delarue, M., Poch, O., Gangloff, J., and Moras, D. (1990) Nature 347, 203-206 [CrossRef][Medline] [Order article via Infotrieve]
  2. Cusack, S., Berthet-Colominas, C., Härtlein, M., Nassar, N., and Leberman, R. (1990) Nature 347, 249-255 [CrossRef][Medline] [Order article via Infotrieve]
  3. Houtondji, C., Dessen, P., and Blanquet, S. (1986) Biochimie 68, 1071-1078 [Medline] [Order article via Infotrieve]
  4. Webster, T., Tsai, H., Kula, M., Mackie, G. A., and Schimmel, P. (1984) Science 226, 1315-1317 [Medline] [Order article via Infotrieve]
  5. Rossmann, M. G., Moras, D., and Olsen, K. W. (1974) Nature 250, 194-199 [Medline] [Order article via Infotrieve]
  6. Cusack, S., Härtlein, M., and Leberman, R. (1991) Nucleic Acids Res. 13, 3489-3498
  7. Ruff, M., Krishnaswamy, S., Boeglin, M., Poterszman, A., Mitschler, A., Podjarny, A., Rees, B., Thierry, J. C., and Moras, D. (1991) Science 252, 1682-1689 [Medline] [Order article via Infotrieve]
  8. Cavarelli, J., Rees, B., Ruff, M., Thierry, J.-C., and Moras, D. (1993) Nature 362, 181-184 [CrossRef][Medline] [Order article via Infotrieve]
  9. Mosyak, L., and Safro, M. (1993) Biochimie 75, 1091-1098 [Medline] [Order article via Infotrieve]
  10. Belrhali, H., Yaremchuk, A., Tukalo, M., Larsen, K., Berthet-Colominas, C., Leberman, R., Beijer, B., Sproat, B., Als-Nielsen, J., Grübel, G., Legrand, J.-F., Lehmann, M., and Cusack, S. (1994) Science 263, 1432-1436 [Medline] [Order article via Infotrieve]
  11. Belrhali, H., Yaremchuk, A., Tukalo, M., Berthet-Colominas, C., Rasmussen, B., Bösecke, P., Diat, O., and Cusack, S. (1995) Structure 3, 341-352 [Medline] [Order article via Infotrieve]
  12. Biou, V., Yaremchuk, A., Tukalo, M., and Cusack, S. (1994) Science 263, 1404-1410 [Medline] [Order article via Infotrieve]
  13. Cusack, S., Yaremchuk, A., and Tukalo, M. (1996) EMBO J. 15, 2834-2842 [Abstract]
  14. Cavarelli, J., Eriani, G., Rees, B., Ruff, M., Boeglin, M., Mitschler, A., Martin, F., Gangloff, J., Thierry, J.-C., and Moras, D. (1994) EMBO J. 13, 327-337 [Abstract]
  15. Poterszman, A., Delarue, M., Thierry, J.-C., and Moras, D. (1994) J. Mol. Biol. 244, 158-167 [CrossRef][Medline] [Order article via Infotrieve]
  16. Cusack, S. (1995) Nat. Struct. Biol. 2, 824-831 [Medline] [Order article via Infotrieve]
  17. Fersht, A. R. (1987) Biochemistry 26, 8031-8037 [Medline] [Order article via Infotrieve]
  18. Vincent, C., Borel, F., Willson, J. C., Leberman, R., and Härtlein, M. (1995) Nucleic Acids Res. 23, 1113-1118 [Abstract]
  19. Lu, Y., and Hill, K. A. W. (1994) J. Biol. Chem. 269, 12137-12141 [Abstract/Free Full Text]
  20. Sever, S., Rogers, K., Rogers, M. J., Carter, C., and Söll, D. (1996) Biochemistry 35, 32-40 [CrossRef][Medline] [Order article via Infotrieve]
  21. Borel, F., Vincent, C., Leberman, R., and Härtlein, M. (1994) Nucleic Acids Res. 22, 2963-2969 [Abstract]
  22. Ibba, M., Thomann, H.-U., Hong, K.-W., Sherman, J. M., Weygand-Durasevic, I., Sever, S., Stange-Thomann, N., Praetorius, M., and Söll, D. (1995) Nucleic Acids Symp. Ser. 33, 40-42 [Medline] [Order article via Infotrieve]
  23. Härtlein, M., and Cusack, S. (1995) J. Mol. Evol. 40, 519-530 [Medline] [Order article via Infotrieve]
  24. Saks, M. E., and Sampson, J. R. (1995) J. Mol. Evol. 40, 509-518 [Medline] [Order article via Infotrieve]
  25. Eriani, G., Cavarelli, J., Martin, F., Ador, L., Rees, B., Thierry, J.-C., Gangloff, J., and Moras, D. (1995) J. Mol. Evol. 40, 499-508 [Medline] [Order article via Infotrieve]
  26. Nagel, G. M., and Doolittle, R. F. (1995) J. Mol. Evol. 40, 487-498 [Medline] [Order article via Infotrieve]
  27. de Pouplana, L. R., Frugier, M., Quinn, C. L., and Schimmel, P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 166-170 [Abstract/Free Full Text]
  28. Johnston, M., Andrews, S., Brinkman, R., Cooper, J., Ding, H., Dover, J., Du, Z., Favello, A., Fulton, L., Gattung, S., Geisel, C., Kirsten, J., Kucaba, T., Hillier, L., Jier, M., Johnston, L., Langston, Y., Latreille, P., Louis, E. J., Macri, C., Mardis, E., Menezes, S., Mouser, L., Nhan, M., Rifkin, L., Riles, L., St. Peter, H., Trevaskis, E., Vaughan, K., Vignati, D., Wilcox, L., Wohldman, P., Waterston, R., Wilson, R., and Vaudin, M. (1994) Science 265, 2077-2082 [Medline] [Order article via Infotrieve]
  29. Weygand-Durasevic, I., Lenhard, B., Filipic, S., and Söll, D. (1996) J. Biol Chem. 271, 2455-2461 [Abstract/Free Full Text]
  30. Weygand-Durasevic, I., Ban, N., Jahn, D., and Söll, D. (1993) Eur. J. Biochem. 214, 869-877 [Abstract]
  31. Guthrie, C., and Fink, G. R. (1991) Guide to Yeast Genetics and Molecular Biology, Academic Press, Inc., New York
  32. Weygand-Durasevic, I., Schwob, E., and Söll, D. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 210-214
  33. Calendar, R., and Berg, P. (1966) Biochemistry 5, 1681-1690 [Medline] [Order article via Infotrieve]
  34. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680 [Abstract]
  35. Felsenstein, J. (1989) Cladistics 5, 164-166
  36. Myers, E. W., and Miller, W. (1988) Comp. Appl. Biosci. 4, 11-17 [Abstract]
  37. Peitsch, M. C. (1996) Biochem. Soc. Trans. 24, 274-279 [Medline] [Order article via Infotrieve]
  38. Nakai, K., and Kanehisa, M. (1992) Genomics 14, 897-911 [Medline] [Order article via Infotrieve]
  39. Brown, J. R., and Doolittle, W. F. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2441-2445 [Abstract]
  40. Weygand-Durasevic, I., and Jerala, R. (1990) Period. Biol. 92, 295-304
  41. Sidorik, L. L., Gudzera, O. I., Dragovoz, D. A., Tukalo, M. A., and Beresten, S. F. (1991) FEBS Lett. 292, 76-78 [CrossRef][Medline] [Order article via Infotrieve]
  42. Fujinaga, M., Berthet-Colominas, C., Yaremchuk, A. D., Tukalo, M. A., and Cusack, S. (1993) J. Mol. Biol. 234, 222-233 [CrossRef][Medline] [Order article via Infotrieve]
  43. Price, S., Cusack, S., Borel, F., Berthet-Colominas, C., and Leberman, R. (1993) FEBS Lett. 324, 167-170 [CrossRef][Medline] [Order article via Infotrieve]
  44. Himeno, H., Hasegawa, T., Ueda, T., Watanabe, K., and Shimizu, M. (1990) Nucleic Acids Res. 18, 6815-6819 [Abstract]
  45. Normanly, J., Ollick, T., and Abelson, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5680-5684 [Abstract]
  46. Asahara, H., Himeno, H., Tamura, K., Nameki, N., Hasegawa, T., and Shimizu, M. (1994) J. Mol. Biol. 236, 738-748 [CrossRef][Medline] [Order article via Infotrieve]
  47. Wu, X. Q., and Gross, H. J. (1993) Nucleic Acids Res. 21, 5589-5594 [Abstract]
  48. Ibba, M., Hong, K.-W., Sherman, J. M., Sever, S., and Söll, D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6953-6958 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.